More Business Wire
View Older Stories View Newer Stories-
Innovare International Announces New One-Person Shoveling Tool for Emergency Sandbag Filling
-
T-Mobile Launches Second Corporate Venture Capital Fund to Fuel the Next Generation of Connected Products and Services
-
Mythic Therapeutics Receives FDA Fast Track Designation for MYTX-011 for Patients with Non-Small Cell Lung Cancer (NSCLC) with cMET Overexpression
-
Investors Double-Down on RealDefense with Additional Financing To Accelerate Corporate Acquisitions and Strengthen Balance Sheet
-
Newegg Introduces Graphics Card Trade-In Program
-
Jackson Healthcare Ranked #8 on Global List of Top 100 Inspiring Workplaces
-
Call for Substitute Teachers Issued in Dallas/Fort Worth
-
NTT Research Boosts Scientific Teams with Nine New Hires
-
Soccer Star Kellyn Acosta Joins Yerbaé’s Advisory Board, Sports and Entertainment
-
MEDIA ALERT: Wolters Kluwer details potential inflation adjusted impact for U.S. taxpayers in 2024
-
TD SYNNEX Reports Fiscal 2023 Third Quarter Results
-
Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
-
Blend Income Expands Verification Coverage through New Assets-Derived Income Capability
-
Reunite Families and Cut Costs with Goose Insurance App
-
Eric Ramos Joins Alliant Insurance Services’ Tribal First Team in Sacramento
-
TAYLOR SWIFT | THE ERAS TOUR Concert Film Goes Global – AMC Theatres® to Bring This Record-setting Concert Film Theatrical Event to More Than 100 Countries Worldwide Beginning October 13
-
Sepion Technologies Opens One of Largest Separator Coating Facilities for Lithium-Metal Batteries in North America
-
Textron Aviation Announces Confirmed Order for First 20 Cessna Grand Caravan EX Aircraft From Surf Air Mobility
-
Sherwood Partners Launches Sherwood Advisory Services and Appoints Spencer Ware Managing Partner of New Advisory Group
-
Clio Fiber brings high-speed broadband to southern Italy with disaggregated Adtran solution
-
The Radoff-Sudbury Group Files Definitive Proxy and Issues Letter to LifeVantage Corporation Stockholders
-
CrowdStrike Hosts Today’s “The Washington Post Live” Cyber Event Featuring Lisa Monaco, Chris Krebs, Eric Goldstein, Chris Painter and CrowdStrike’s Drew Bagley
-
Armanino Foods of Distinction, Inc. Maintains Its Regular Quarterly Dividend of $.033 Per Share
-
Viz.ai Announces Expansion Into Outpatient Ambulatory Centers to Accelerate Clinical Trial Recruitment in Heart Failure
-
Acushnet Holdings Corp. Announces Offering of Senior Notes
-
ON24 and NetLine Join Forces to Help Enterprise Customers Supercharge Reach and ROI
-
Genius Sports launches BetVision, a game-changing, immersive sports betting experience including NFL live game video
-
Yamaha Receives Chattahoochee Riverkeeper River Guardian Award
-
Energy Transfer and Crestwood Announce Expiration of Hart-Scott-Rodino Act Waiting Period
-
Waltz Health Brings Marketplace Drug Savings Solution to Health Plans and Employers
-
Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of Anti-LILRB2 Antibody ES009 in Australia
-
Conservation X Labs Shares 25 Impactful Solutions for Biodiversity Conservation
-
General Atlantic Announces Leadership Appointments
-
Allstate Debuts Coaching Mural to Develop Youth Soccer Players
-
Cybersecurity, the Most Important Challenge for Modatelas Met With Help From Hillstone Networks
-
Edgewise Therapeutics Announces Initiation of GRAND CANYON, a Global Pivotal Study of EDG-5506 in Becker Muscular Dystrophy (Becker)
-
Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation
-
DigitalOcean Launches Managed Kafka Offering
-
Workers at Johanna Foods Overwhelmingly Authorize Strike
-
UPS Recruits 100,000 Seasonal Workers For The 2023 Holiday Season
-
COTA Announces New Data Platform to Accelerate Cancer Research and Advance Generative AI Models for Cancer Care
-
OS Therapies Announces Full Enrollment in PhIIb Clinical Trial AOST-2121 in Recurred, Resected Osteosarcoma with OST-HER2 (Listeria monocytogenes) for Delay or Prevention of Recurrence
-
o9 Survey Reveals That Consumers’ Perceptions of Supply Chain Disruptions Are Shifting Their Purchasing Behaviors
-
Sierra Space Increases Total Investment to a Record $1.7 Billion with $290M Series B Funding, Bringing Valuation to $5.3 Billion
-
Crescent Capital Group Announces Hiring of Jason Moss as Managing Director, Head of Western U.S. Region in the Investor Solutions Group
-
Mattel Announces Pictionary® Vs. AI, the First Physical Board Game to Integrate AI into Gameplay
-
A Record Share of Homebuyers Are Relocating, Many to Places Endangered By Climate Change
-
World Economic Forum Welcomes ProducePay as Innovator Positively Shaping Global Climate and Food Agenda
-
Anzu Partners Closes Third Venture Fund Focused on Companies Enabling Next-Gen Solutions in Clean Tech, Industrial, and Life Sciences Technologies
-
Reveal Group Awarded Approved Partner Status for SS&C Blue Prism Document Automation
